Literature DB >> 26340874

Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.

Don B Sanders1, Aliza Fink2, Nicole Mayer-Hamblett3, Michael S Schechter4, Gregory S Sawicki5, Margaret Rosenfeld6, Patrick A Flume7, Wayne J Morgan8.   

Abstract

OBJECTIVE: To determine whether severity of lung disease at age 6 years is associated with changes in nutritional status before age 6 within individual children with cystic fibrosis (CF). STUDY
DESIGN: Children with CF born between 1994 and 2005 and followed in the CF Foundation Patient Registry from age ≤2 through 7 years were assessed according to changes in annualized weight-for-length (WFL) percentiles between ages 0 and 2 years and body mass index (BMI) percentiles between ages 2 and 6 years. The association between growth trajectories before age 6 and forced expiratory volume in 1 second (FEV1)% predicted at age 6-7 years was evaluated using multivariable linear regression.
RESULTS: A total of 6805 subjects met inclusion criteria. Children with annualized WFL-BMI always >50th percentile (N = 1323 [19%]) had the highest adjusted mean (95% CI) FEV1 at 6-7 years (101.8 [100.1, 103.5]). FEV1 at 6-7 years for children whose WFL-BMI increased >10 percentile points by age 6 years was 98.3 (96.6, 100.0). This was statistically significantly higher than FEV1 for children whose WFL-BMI was stable (94.4 [92.6, 96.2]) or decreased >10 percentile points (92.9 [91.1, 94.8]). Among children whose WFL-BMI increased >10 percentile points, achieving and maintaining WFL-BMI >50th percentile at younger ages was associated with significantly higher FEV1 at 6-7 years.
CONCLUSIONS: Within-patient changes in nutritional status in the first 6 years of life are significantly associated with FEV1 at age 6-7 years. The establishment of a clear relationship between early childhood growth measurements and later lung function suggests that early nutritional interventions may impact on eventual lung health.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26340874      PMCID: PMC5017309          DOI: 10.1016/j.jpeds.2015.07.044

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  30 in total

1.  Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.

Authors:  Margaret Rosenfeld; Julia Emerson; Sharon McNamara; Kelli Joubran; George Retsch-Bogart; Gavin R Graff; Hector H Gutierrez; Jamshed F Kanga; Thomas Lahiri; Blake Noyes; Bonnie Ramsey; Clement L Ren; Michael Schechter; Wayne Morgan; Ronald L Gibson
Journal:  Pediatr Pulmonol       Date:  2010-09

2.  Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

Authors:  Andrew T Braun; Philip M Farrell; Claude Ferec; Marie Pierre Audrezet; Anita Laxova; Zhanhai Li; Michael R Kosorok; Marjorie A Rosenberg; William M Gershan
Journal:  J Cyst Fibros       Date:  2005-11-04       Impact factor: 5.482

3.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

4.  Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis.

Authors:  M Corey; L Edwards; H Levison; M Knowles
Journal:  J Pediatr       Date:  1997-12       Impact factor: 4.406

5.  Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis.

Authors:  Elizabeth H Yen; Hebe Quinton; Drucy Borowitz
Journal:  J Pediatr       Date:  2012-10-11       Impact factor: 4.406

6.  Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States.

Authors:  Alexandra L Quittner; Michael S Schechter; Lawrence Rasouliyan; Tmirah Haselkorn; David J Pasta; Jeffrey S Wagener
Journal:  Chest       Date:  2009-10-09       Impact factor: 9.410

7.  Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention.

Authors:  M S Marcus; S A Sondel; P M Farrell; A Laxova; P M Carey; R Langhough; E H Mischler
Journal:  Am J Clin Nutr       Date:  1991-09       Impact factor: 7.045

8.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

9.  Mealtime behaviors in families of infants and toddlers with cystic fibrosis.

Authors:  Scott W Powers; Monica J Mitchell; Susana R Patton; Kelly C Byars; Elissa Jelalian; Mary M Mulvihill; Melbourne F Hovell; Lori J Stark
Journal:  J Cyst Fibros       Date:  2005-09       Impact factor: 5.482

Review 10.  Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review.

Authors:  Virginia A Stallings; Lori J Stark; Karen A Robinson; Andrew P Feranchak; Hebe Quinton
Journal:  J Am Diet Assoc       Date:  2008-05
View more
  23 in total

1.  Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor.

Authors:  Michael S Stalvey; Jesse Pace; Minoo Niknian; Mark N Higgins; Valerie Tarn; Joy Davis; Sonya L Heltshe; Steven M Rowe
Journal:  Pediatrics       Date:  2017-02       Impact factor: 7.124

2.  The effects of ivacaftor on CF fatty acid metabolism: An analysis from the GOAL study.

Authors:  Michael Glenn O'Connor; Adam Seegmiller
Journal:  J Cyst Fibros       Date:  2016-07-26       Impact factor: 5.482

3.  Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study.

Authors:  Michael Glenn O'Connor; Kelly Thomsen; Rebekah F Brown; Michael Laposata; Adam Seegmiller
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2016-08-27       Impact factor: 4.006

4.  Zinc status and growth in infants and young children with cystic fibrosis.

Authors:  Sarah E Bauer; HuiChuan J Lai; Catherine M McDonald; Fadi Asfour; James E Slaven; Clement L Ren
Journal:  Pediatr Pulmonol       Date:  2021-09-17

5.  Impact of guideline-recommended dietitian assessments on weight gain in infants with cystic fibrosis.

Authors:  Thida Ong; Frankline M Onchiri; Maria T Britto; Sonya L Heltshe; Larry G Kessler; Michael Seid; Bonnie W Ramsey
Journal:  J Cyst Fibros       Date:  2021-08-26       Impact factor: 5.482

6.  Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis.

Authors:  Don B Sanders; Zhumin Zhang; Philip M Farrell; HuiChuan J Lai
Journal:  J Cyst Fibros       Date:  2018-02-01       Impact factor: 5.482

7.  Growth trajectories and oxygen use in neuroendocrine cell hyperplasia of infancy.

Authors:  Rebekah J Nevel; Errine T Garnett; Deneen A Schaudies; Lisa R Young
Journal:  Pediatr Pulmonol       Date:  2018-02-02

Review 8.  Background and Epidemiology.

Authors:  Don B Sanders; Aliza K Fink
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

Review 9.  Current and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implications.

Authors:  Claire Edmondson; Jane C Davies
Journal:  Ther Adv Chronic Dis       Date:  2016-05-01       Impact factor: 5.091

10.  Hyperinflation is associated with increased respiratory rate and is a more sensitive measure of cystic fibrosis lung disease during infancy compared to forced expiratory measures.

Authors:  Heather N Muston; James E Slaven; Christina Tiller; Charles Clem; Thomas W Ferkol; Sarath Ranganathan; Stephanie D Davis; Clement L Ren
Journal:  Pediatr Pulmonol       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.